Clinical Trials Logo

Delivery Systems clinical trials

View clinical trials related to Delivery Systems.

Filter by:
  • Completed  
  • Page 1 ·  Next »

NCT ID: NCT01680328 Completed - Clinical trials for Diabetes Mellitus, Type 2

Investigation of Pain During Subcutaneous Injections With Different Injection Speed and Volume Combinations

Start date: August 2012
Phase: Phase 1
Study type: Interventional

This trial is conducted in Europe. The aim of this trial is to assess and describe the pain in relation to subcutaneous (under the skin) injection of different combinations of injection speed and volume with respect to acceptance of the injection pain and backflow.

NCT ID: NCT01516242 Completed - Clinical trials for Diabetes Mellitus, Type 2

Evaluation of Safety and Parameters of Application Technique

Start date: October 2006
Phase: N/A
Study type: Observational

This study is conducted in Europe. The aim of the study is to monitor patients changing therapy from syringe to insulin delivery system as prescribed by the treating physician in Slovakia.

NCT ID: NCT01500486 Completed - Clinical trials for Growth Hormone Disorder

Observational Study of Norditropin NordiFlex® With NordiFlex PenMate™

Start date: January 2007
Phase: N/A
Study type: Observational

This study is conducted in Europe. The aim of this study is to evaluate ease of injection of growth hormone in patients using Norditropin NordiFlex® with NordiFlex PenMate™. Convenience and tolerability of NordiFlex PenMate™ - an automatic injection and a needle hiding device - is also evaluated.

NCT ID: NCT01454024 Completed - Clinical trials for Diabetes Mellitus, Type 2

Evaluating Safety of NovoPen® 3 and/or FlexPen® Devices in Routine Clinical Practice

Start date: November 2011
Phase: N/A
Study type: Observational

This study is conducted in Asia. The aim of of this study is to evaluate the safety of NovoPen® 3 and/or FlexPen® devices (if available on the market) measured by the number of adverse events and technical complaints in patients with type 1 and type 2 diabetes in routine clinical practice.

NCT ID: NCT01327924 Completed - Clinical trials for Chronic Kidney Disease

Usability and Tolerability of the Norditropin NordiFlex® Injection Device in Children Never Previously Treated With Growth Hormone

Start date: April 2011
Phase: N/A
Study type: Observational

This study is conducted in Europe. The purpose of this study is to assess the impact on daily life for children new to using a growth hormone injection device.

NCT ID: NCT01245374 Completed - Clinical trials for Chronic Kidney Disease

Norditropin NordiFlex® Device Compared to the Device Previously Used by Patients or Parents

Start date: November 2010
Phase: Phase 4
Study type: Interventional

This study is conducted in Europe. The aim of this study is to compare the easiness of use of Norditropin NordiFlex® device to the device previously used by patients or parents.

NCT ID: NCT01180530 Completed - Diabetes Clinical Trials

Observational Study of NovoPen Echo® on Safety and Treatment Satisfaction in Children and Adolescents With Type 1 Diabetes

REMIND™
Start date: October 2010
Phase: N/A
Study type: Observational

This study is conducted in Asia, Europe and North America. The aim of this observational study is to evaluate the safety of NovoPen Echo® by collecting safety information (incidence of technical complaints related to adverse reactions). Study duration: 12-18 weeks.

NCT ID: NCT01024218 Completed - Diabetes Clinical Trials

Preference Study Between NovoFine® Autocover™ and a NovoFine® 8 mm Needle

Start date: December 1, 2004
Phase: Phase 4
Study type: Interventional

This trial is conducted in Europe. The aim of this clinical trial is to assess the preference of 2 different needles used by nurses and health assistants. The trial consists of a handling test followed by a 12 week cross-over study.

NCT ID: NCT00872560 Completed - Diabetes Clinical Trials

Comparison of 2 NovoFine® Needles on the Reflux of Insulin

Start date: January 20, 1998
Phase: Phase 3
Study type: Interventional

This trial is conducted in Europe. This trial aims to ensure that there is no substantial clinically relevant difference between the two Novo Nordisk needles NovoFine® 6 x 0.30 mm and NovoFine® 8 x 0.30 mm on reflux of insulin back to the surface of cutis.

NCT ID: NCT00871416 Completed - Clinical trials for Diabetes Mellitus, Type 2

Localisation of Potential Insulin Deposits in Normal Weight and Obese Diabetics Using 6 mm and 12 mm Long Needles

Start date: April 9, 1997
Phase: Phase 3
Study type: Interventional

This trial is conducted in Europe. The primary aim of this clinical trial is to locate and compare simulated insulin injections (injections of sterile atmospheric air) in normal weight and obese patients with diabetes mellitus. Injections are done with 6 mm and 12 mm needles with and without lifting of skin fold at different injection sites.